My NCBI | Sign In
RSS Settings
  • Search: Pellmé F[au]

Display Settings:

Format
Sort by

Send to:

Choose Destination

    Results: 4

    1.

    Insulin sensitivity, insulin release and glucagon-like peptide-1 levels in persons with impaired fasting glucose and/or impaired glucose tolerance in the EUGENE2 study.

    Laakso M, Zilinskaite J, Hansen T, Boesgaard TW, Vänttinen M, Stancáková A, Jansson PA, Pellmé F, Holst JJ, Kuulasmaa T, Hribal ML, Sesti G, Stefan N, Fritsche A, Häring H, Pedersen O, Smith U; EUGENE2 Consortium.

    Diabetologia. 2008 Mar;51(3):502-11. Epub 2007 Dec 14.PMID: 18080106 [PubMed - indexed for MEDLINE]Related articles

    2.

    Effect of the interleukin-6 (-174) g/c promoter polymorphism on adiponectin and insulin sensitivity.

    Yang X, Jansson PA, Pellmé F, Laakso M, Smith U.

    Obes Res. 2005 May;13(5):813-7.PMID: 15919832 [PubMed - indexed for MEDLINE]Related articles

    3.

    A novel cellular marker of insulin resistance and early atherosclerosis in humans is related to impaired fat cell differentiation and low adiponectin.

    Jansson PA, Pellmé F, Hammarstedt A, Sandqvist M, Brekke H, Caidahl K, Forsberg M, Volkmann R, Carvalho E, Funahashi T, Matsuzawa Y, Wiklund O, Yang X, Taskinen MR, Smith U.

    FASEB J. 2003 Aug;17(11):1434-40.PMID: 12890697 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Circulating adiponectin levels are reduced in nonobese but insulin-resistant first-degree relatives of type 2 diabetic patients.

    Pellmé F, Smith U, Funahashi T, Matsuzawa Y, Brekke H, Wiklund O, Taskinen MR, Jansson PA.

    Diabetes. 2003 May;52(5):1182-6.PMID: 12716750 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Filter your results:

    Find related data

    Search details

    » See more...

    Recent activity